Physician profile
Robert Chesne
NPI 1497751689
$2,772.23
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $757 · 2020: $461 · 2021: $836 · 2022: $660 · 2023: $59.01.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $59.01.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $59.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,043.13 | 2019-2023 | |
| Amgen INC. | $473.82 | 2019-2022 | |
| Abbott Laboratories | $205.42 | 2020-2022 | |
| Esperion Therapeutics, INC. | $152.95 | 2020-2022 | |
| Janssen Pharmaceuticals, INC | $137.69 | 2019-2022 | |
| Pfizer INC. | $128.18 | 2019-2022 | |
| Novo Nordisk INC | $125.39 | 2020-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $106.88 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $85.26 | 2019 | |
| Astellas Pharma US INC | $56.67 | 2020-2021 | |
| Alnylam Pharmaceuticals INC. | $52.91 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $40.60 | 2019 | |
| Impulse Dynamics (USA) INC. | $39.19 | 2023 | Optimizer |
| E.R. Squibb & Sons, L.L.C. | $27.03 | 2019-2022 | |
| Preventice Services, LLC | $21.98 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $20.56 | 2021 | |
| Medtronic, INC. | $16.28 | 2021 | |
| Merck Sharp & Dohme LLC | $14.25 | 2022 | |
| Medtronic Vascular, INC. | $12.39 | 2019 | |
| Arbor Pharmaceuticals, INC. | $11.65 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Chesne listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.